Bioelectronics Corp (BIEL)

[3331]

Path to a dime:
Looks like reaching $2 million annual revenue should be break even - cash flow positive (maybe slightly profitable) and would likely result in a pps of about .01. Each additional $2.5 million/year should result in an additional .01 increase in pps. Each of the following potential catalysts could result in more than $2.5 million annual revenue:
1) Veterans Administration
2) Veterinary company contract
3) Haleon

Result: pps = .04

Additional revenue could be generated from new FDA clearances, vagus nerve patent, etc. Initiating a stock buyback program after all of the loans are paid off would propel the pps much higher (nickel to a dime).